छोड़कर सामग्री पर जाएँ
Buy Hindustan Unilever; target of Rs 3109: KR Choksey

Buy Hindustan Unilever; target of Rs 3109: KR Choksey

KR Choksey is bullish on Hindustan Unilever has recommended buy rating on the stock with a target price of Rs 3109 in its research report dated May 02, 2023.

Read More

​ KR Choksey is bullish on Hindustan Unilever has recommended buy rating on the stock with a target price of Rs 3109 in its research report dated May 02, 2023. KR Choksey is bullish on Hindustan Unilever has recommended buy rating on the stock with a target price of Rs 3109 in its research report dated May 02, 2023.  Moneycontrol Latest News Read More  

KR Choksey is bullish on Hindustan Unilever has recommended buy rating on the stock with a target price of Rs 3109 in its research report dated May 02, 2023.

Hold Mahindra Finance; target of Rs 270: Emkay Global Financial

Hold Mahindra Finance; target of Rs 270: Emkay Global Financial

Emkay Global Financial recommended hold rating on Mahindra Finance with a target price of Rs 270 in its research report dated April 29, 2023.

Read More

​ Emkay Global Financial recommended hold rating on Mahindra Finance with a target price of Rs 270 in its research report dated April 29, 2023. Emkay Global Financial recommended hold rating on Mahindra Finance with a target price of Rs 270 in its research report dated April 29, 2023.  Moneycontrol Latest News Read More  

Emkay Global Financial recommended hold rating on Mahindra Finance with a target price of Rs 270 in its research report dated April 29, 2023.

Buy RBL Bank; target of Rs 225: Emkay Global Financial

Buy RBL Bank; target of Rs 225: Emkay Global Financial

Emkay Global Financial is bullish on RBL Bank has recommended buy rating on the stock with a target price of Rs 225 in its research report dated May 01, 2023.

Read More

​ Emkay Global Financial is bullish on RBL Bank has recommended buy rating on the stock with a target price of Rs 225 in its research report dated May 01, 2023. Emkay Global Financial is bullish on RBL Bank has recommended buy rating on the stock with a target price of Rs 225 in its research report dated May 01, 2023.  Moneycontrol Latest News Read More  

Emkay Global Financial is bullish on RBL Bank has recommended buy rating on the stock with a target price of Rs 225 in its research report dated May 01, 2023.

Buy Gravita India; target of Rs 650: Emkay Global Financial

Buy Gravita India; target of Rs 650: Emkay Global Financial

Emkay Global Financial is bullish on Gravita India has recommended buy rating on the stock with a target price of Rs 650 in its research report dated May 02, 2023.

Read More

​ Emkay Global Financial is bullish on Gravita India has recommended buy rating on the stock with a target price of Rs 650 in its research report dated May 02, 2023. Emkay Global Financial is bullish on Gravita India has recommended buy rating on the stock with a target price of Rs 650 in its research report dated May 02, 2023.  Moneycontrol Latest News Read More  

Emkay Global Financial is bullish on Gravita India has recommended buy rating on the stock with a target price of Rs 650 in its research report dated May 02, 2023.

Buy Star Health; target of Rs 685: Emkay Global Financial

Buy Star Health; target of Rs 685: Emkay Global Financial

Emkay Global Financial is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 685 in its research report dated April 29, 2023.

Read More

​ Emkay Global Financial is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 685 in its research report dated April 29, 2023. Emkay Global Financial is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 685 in its research report dated April 29, 2023.  Moneycontrol Latest News Read More  

Emkay Global Financial is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 685 in its research report dated April 29, 2023.

Astec LifeSciences sinks 11% as Q4 earnings take a knock

Astec LifeSciences sinks 11% as Q4 earnings take a knock

The company’s sales tanked 53 percent YoY to Rs 127 crore in Q4 of FY23. It reported a loss of Rs 5 crore as compared to net profit of Rs 43 crore posted a year ago. Operating margin shrunk to 4.3 percent from 24 percent.

Read More

​ The company’s sales tanked 53 percent YoY to Rs 127 crore in Q4 of FY23. It reported a loss of Rs 5 crore as compared to net profit of Rs 43 crore posted a year ago. Operating margin shrunk to 4.3 percent from 24 percent. The company’s sales tanked 53 percent YoY to Rs 127 crore in Q4 of FY23. It reported a loss of Rs 5 crore as compared to net profit of Rs 43 crore posted a year ago. Operating margin shrunk to 4.3 percent from 24 percent.  Moneycontrol Latest News Read More  

The company’s sales tanked 53 percent YoY to Rs 127 crore in Q4 of FY23. It reported a loss of Rs 5 crore as compared to net profit of Rs 43 crore posted a year ago. Operating margin shrunk to 4.3 percent from 24 percent.

hi_INहिन्दी